| Early Detection of Cancer Onset Based on Sensing Field Cancerization at the Organ Level in the Alimentary Tract Using an Integrated Stimulated Raman/Scattering Modality for Endoscopic Real-time in Vivo Measurements (NCT05247346) | University Medical Center Groningen | 2022-07-01 |
| Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients (NCT05411133) | Arbele Pty Ltd | 2022-05-30 |
| Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Patients (NCT04894123) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2022-02-07 |
| Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer (NCT05635149) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2022-01-01 |
| Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer (NCT04963283) | University of Colorado, Denver | 2021-06-23 |
| A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors (NCT04731467) | Famewave Ltd. | 2021-03-19 |
| Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet (NCT04898842) | Royal Surrey County Hospital NHS Foundation Trust | 2021-03-02 |
| Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer (NCT04457284) | Memorial Sloan Kettering Cancer Center | 2020-11-18 |
| A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma (NCT04111172) | Thomas Jefferson University | 2020-11-10 |
| Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer (NCT04108481) | University of Iowa | 2020-10-05 |
| Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors (NCT04870879) | Azienda Ospedaliera di Padova | 2020-10-01 |
| A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer (NCT04474470) | TyrNovo Ltd. | 2020-09-03 |
| To Compare Artificial Intelligence Software Aided Adenoma Detection in Screening Colonoscopies Versus Standard Colonoscopy Without Artificial Intelligence Software Assistance in Participants Between 45 and 75 Years of Age (NCT04196088) | Docbot, Inc. | 2020-06-11 |
| The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal Adenocarcinoma (NCT04430127) | Hôpital Fribourgeois | 2020-04-01 |
| Early Detection of Advanced Adenomas and Colorectal Cancer (NCT06342440) | City of Hope Medical Center | 2020-03-15 |
| A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer (NCT04148378) | ProgenaBiome | 2020-03-02 |
| Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer (NCT03576963) | University of Southern California | 2020-01-30 |
| Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study (NCT04739072) | M.D. Anderson Cancer Center | 2019-11-22 |
| Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT04094688) | Alliance for Clinical Trials in Oncology | 2019-10-29 |
| CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors (NCT02757391) | M.D. Anderson Cancer Center | 2019-08-09 |
| Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver (NCT03366155) | National Cancer Institute (NCI) | 2019-06-24 |
| Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors (NCT03781778) | Fred Hutchinson Cancer Center | 2019-05-07 |
| The Problem of Colorectal Anastomosis Safety (NCT03958500) | Vilnius University | 2019-04-01 |
| Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer (NCT03642067) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-02-12 |
| Nivolumab and Metformin in Patients With Treatment Refractory MSS Colorectal Cancer (NCT03800602) | Emory University | 2019-01-15 |
| Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas (NCT04773769) | Auxilio Mutuo Cancer Center | 2018-11-07 |
| Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma (NCT03708536) | Fujian Cancer Hospital | 2018-11-01 |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas (NCT03715933) | Inhibrx Biosciences, Inc | 2018-10-08 |
| Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma (NCT03376659) | Georgetown University | 2018-08-08 |
| Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases (NCT03599752) | M.D. Anderson Cancer Center | 2018-07-02 |
| Endoscopic Full-Thickness Resection In Colon (NCT03803891) | Fundació Institut Germans Trias i Pujol | 2018-05-01 |
| Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms (NCT03468244) | Changhai Hospital | 2018-05-01 |
| Use of iFOBT in Patients Presenting With Alarm Symptoms of Colorectal Cancer (NCT03367611) | University of Aarhus | 2018-03-15 |
| 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab (NCT03300609) | University of Southern California | 2018-02-27 |
| Colvera for Detection of Disease Recurrence (NCT03706235) | Clinical Genomics Pathology | 2018-02-01 |
| TAS102 in Combination With NAL-IRI in Advanced GI Cancers (NCT03368963) | Emory University | 2018-01-30 |
| VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer (NCT03373188) | Emory University | 2017-12-15 |
| Very Low Carbohydrate Diet Effects to GPS, Serum Lactate and TNF Alpha on Colorectal Cancer (NCT03221920) | Dr. Soetomo General Hospital | 2017-08-05 |
| Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer (NCT03095781) | Emory University | 2017-07-07 |
| Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors (NCT03507998) | Curegenix Inc. | 2017-06-17 |
| The Colorectal Breath Analysis (COBRA) Study (NCT03699163) | Imperial College London | 2017-06-03 |
| Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases (NCT02758951) | Koen Rovers | 2017-06-01 |
| Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors (NCT03149523) | European Georges Pompidou Hospital | 2017-05-01 |
| Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 (NCT03050814) | National Cancer Institute (NCI) | 2017-04-05 |
| PI Pembro in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer (NCT02837263) | University of Wisconsin, Madison | 2016-08-11 |
| Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors (NCT02835833) | University of Alabama at Birmingham | 2016-06-09 |
| TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors (NCT02650635) | Mayo Clinic | 2016-02-05 |
| Study of the Practice of Debiri in France (NCT03369041) | Federation Francophone de Cancerologie Digestive | 2016-02-03 |
| Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal Adenocarcinoma (NCT01844076) | Fox Chase Cancer Center | 2016-01-14 |
| Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies (NCT02638909) | Criterium, Inc. | 2015-12-01 |
| Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer (NCT02413853) | University of Southern California | 2015-11-01 |
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (NCT02292758) | Academic and Community Cancer Research United | 2014-12-12 |
| Oncological Impact of Lateral Nodes in Rectal Cancer (NCT05592873) | Niguarda Hospital | 2014-01-01 |
| Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer (NCT01856322) | National Cancer Institute (NCI) | 2013-04-01 |
| Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases (NCT02709811) | IGEA | 2012-08-01 |
| Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma (NCT01552967) | Sixth Affiliated Hospital, Sun Yat-sen University | 2012-03-01 |
| Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF (NCT01367275) | M.D. Anderson Cancer Center | 2011-08-01 |
| FNA Tumor Sampling for CD137 Modulation: A Pilot Study (NCT01114256) | Stanford University | 2010-03-01 |
| Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer (NCT00593060) | Jeffrey W. Clark, MD | 2007-11-01 |
| Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus (NCT00597506) | Herbert Hurwitz | 2007-10-01 |
| Trends and Outcomes in Laparoscopic Versus Open Surgery for Rectal Cancer (NCT03683446) | Catherine H. Davis, MD | 2005-01-01 |
| Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma (NCT00034190) | Achieve Life Sciences | 2002-03-01 |
| Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma (NCT00168155) | Alberta Health services | 2002-01-01 |
| Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma (NCT00165217) | Dana-Farber Cancer Institute | 2001-11-01 |